Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019

Daniel A Puebla Neira1, Abigail Watts1, Justin Seashore1

  • 1Division of Pulmonary, Critical Care and Sleep Medicine Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, United States.

Insights

Chronic obstructive pulmonary disease (COPD) increases mortality risk for hospitalized COVID-19 patients. This risk is particularly significant for females and individuals aged 40-79.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Controversy exists regarding chronic obstructive pulmonary disease (COPD) as an independent risk factor for mortality in Coronavirus Disease 2019 (COVID-19) hospitalized patients.
  • This study investigated the hypothesis that COPD exacerbates mortality risk in COVID-19 inpatients.

Purpose of the Study:

  • To determine if COPD independently elevates mortality risk among individuals hospitalized with COVID-19.
  • To analyze the interaction of COPD with demographic factors like sex and age in COVID-19 mortality.

Main Methods:

  • Retrospective cohort analysis of 31,526 patients diagnosed with COVID-19 between February 10, 2020, and November 10, 2020.
  • Utilized electronic health records from U.S. facilities (Optum COVID-19 data) for hospitalized patients within 14 days of diagnosis.
  • Employed univariate and multivariate analyses to assess mortality odds ratios and confidence intervals.

Main Results:

  • Overall mortality was 9.6% (3030 deaths).
  • COPD patients exhibited higher mortality (14.02%) compared to non-COPD patients (8.8%).
  • Multivariate analysis confirmed COPD as a significant risk factor (OR 1.33; 95% CI 1.18 to 1.50).
  • Increased mortality risk associated with COPD was significant in females and patients aged 40-79, but not in males.

Conclusions:

  • Chronic obstructive pulmonary disease is identified as an independent risk factor for mortality in adults aged 40-79 hospitalized with COVID-19.
  • The findings highlight the critical impact of COPD on COVID-19 outcomes within specific demographic groups.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
478
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
696
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K